Tirzepatide

Revision as of 09:15, 22 March 2026 by Danbot (talk | contribs) (Add References section)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tirzepatide is a dual GIP and GLP-1 agonist approved for the treatment of type 2 diabetes and also used off-label for obesity treatment

Side Effects

  • Pancreatitis
  • Nausea
  • Vomiting
  • Abdominal pain

References

Retrieved from "https://www.wikem.org/w/index.php?title=Tirzepatide&oldid=389022"